Prenosis is transforming clinical diagnosis with artificial intelligence that leverages holistic molecular and clinical data.
Location: United States
Employees: 11-50
Total raised: $60M
Founded date: 2014
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.02.2026 | Series A | $40M | LabCorp |
| 15.03.2022 | - | $20M | Enterprise... |
Mentions in press and media 11
| Date | Title | Description |
| 03.02.2026 | Prenosis Secures $40M, Fuels AI Revolution in Critical Care | Prenosis secured $40M to transform critical care. A $20M Series A funds commercialization of Sepsis ImmunoScore, the FDA-authorized AI sepsis diagnostic. A $20M BARDA contract backs a pivotal trial for an AI companion diagnostic for cortico... |
| 02.02.2026 | Prenosis Raises $20M in Series A Funding | Prenosis, a Chicago, IL-based biology-based technology company delivering integrated diagnostics and therapeutics, raised $20M in Series A funding. The round was led by PACE Healthcare Capital, with premier co-investors including UC Investm... |
| 29.01.2026 | Prenosis Secures $40M to Build the Precision Medicine Network for Critical Care | What You Should Know The News: Prenosis has secured a combined $40M in new capital—split evenly between a $20M Series A led by PACE Healthcare Capital and a $20M federal contract from BARDA. The Tech: The funding supports the commercial rol... |
| 29.01.2026 | Prenosis Raises $20M Series A Round | CHICAGO, IL, Prenosis, a biology-based technology company delivering integrated diagnostics and therapeutics, has completed a Series A financing round. >> Click here for more funding data on Prenosis >> To export Prenosis fundi... |
| 03.04.2024 | First AI-Powered Diagnostic Tool For Sepsis Gets Greenlight From FDA | Joseph Henry, Tech Times 03 April 2024, 10:04 am Health technology innovator Prenosis has achieved a life-changing milestone with the U.S. Food and Drug Administration (FDA) granting approval to its groundbreaking AI-powered diagnostic tool... |
| 10.03.2022 | Precision Medicine Startup Prenosis Raises $20M for Acute Care Solutions, Starting with Sepsis | What You Should Know: – Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding i... |
| 14.10.2021 | Prenosis, Roche Partner to Combat Hospital Sepsis Using Precision Diagnostics | What You Should Know: – Prenosis Inc., a precision diagnostics company transforming clinical diagnosis with artificial intelligence, announced today the expansion of an existing partnership with Roche Diagnostics that will total close to $6... |
| 08.04.2019 | MedCity INVEST unveils health IT startups selected for Pitch Perfect competition | The MedCity INVEST conference brings together investors and executives from healthcare organizations with promising startups in the biopharma, diagnostics, medical device, health IT, and health services sectors. The Pitch Perfect startup co... |
| - | MedCity INVEST unveils health IT startups selected for Pitch Perfect competition | The MedCity INVEST conference brings together investors and executives from healthcare organizations with promising startups in the biopharma, diagnostics, medical device, health IT, and health services sectors. The Pitch Perfect startup co... |
| - | Prenosis | “At Prenosis we believe healthcare should be tailored to individual biology. With our data-driven approach to fast-moving biology in acute care environments, we’re ushering in a new era of precision medicine in acute care.” |
Show more